Skip to main content
. 2021 Jan 15;14:445–454. doi: 10.2147/OTT.S258175

Figure 6.

Figure 6

Schematic diagram of adverse effect of hyper-O-GlcNAcylation in the progression of bladder cancer. Up-regulation of O-GlcNAcylation level with PuGNAc and GlcNAc treatment promotes the expression and stability of NUSAP1 protein, and accelerates the proliferation and tumorigenesis and represses the apoptosis of bladder cancer cells.